Remote Jobs at Ardelyx, Inc.
Find your next remote opportunity · 0 Open Positions
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.
Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor).
Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S.
Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan.
A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma.
Knight Therapeutics commercializes IBSRELA in Canada.
Community Guidelines: https://rb.gy/07ltg3
No jobs currently available at Ardelyx, Inc..